Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (661-670 of 6,834) with videos related to

Pageof 684
Sort By:
Nature Reviews. Drug Discovery|February 10, 2025
FDA approves TROP2-targeted antibody-drug conjugate for breast cancerAsher Mullard
Nature Reviews. Drug Discovery|November 15, 2024
FDA approves L-amino acid decarboxylase deficiency gene therapyAsher Mullard
Nature Reviews. Drug Discovery|December 12, 2025
Calico, Alphabet's anti-ageing play, goes it aloneAsher Mullard
Nature Reviews. Drug Discovery|November 26, 2025
Novel antimalarial passes key phase III testAsher Mullard
Nature Reviews. Drug Discovery|December 17, 2025
FDA approves first gene therapy from a non-profit organization, but pricing and access questions remainAsher Mullard
Nature Reviews. Drug Discovery|November 5, 2025
FDA approves PDE4 inhibitor for IPFAsher Mullard
Entropy (Basel, Switzerland)|December 24, 2025
Entropy and Variational Formulation of Relativistic Fluid DynamicsAsher Yahalom
Nature Biotechnology|August 8, 2014
EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appealAsher Mullard
Nature Reviews. Drug Discovery|February 2, 2013
2012 FDA drug approvalsAsher Mullard
Journal of Neurosurgery. Spine|February 26, 2013
Harrington and scoliosisMarc Asher
Pageof 684

Showing results (661-670 of 6,834) with videos related to

Sort By:
Pageof 684
Nature Reviews. Drug Discovery|February 10, 2025
FDA approves TROP2-targeted antibody-drug conjugate for breast cancerAsher Mullard
Nature Reviews. Drug Discovery|November 15, 2024
FDA approves L-amino acid decarboxylase deficiency gene therapyAsher Mullard
Nature Reviews. Drug Discovery|December 12, 2025
Calico, Alphabet's anti-ageing play, goes it aloneAsher Mullard
Nature Reviews. Drug Discovery|November 26, 2025
Novel antimalarial passes key phase III testAsher Mullard
Nature Reviews. Drug Discovery|December 17, 2025
FDA approves first gene therapy from a non-profit organization, but pricing and access questions remainAsher Mullard
Nature Reviews. Drug Discovery|November 5, 2025
FDA approves PDE4 inhibitor for IPFAsher Mullard
Entropy (Basel, Switzerland)|December 24, 2025
Entropy and Variational Formulation of Relativistic Fluid DynamicsAsher Yahalom
Nature Biotechnology|August 8, 2014
EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appealAsher Mullard
Nature Reviews. Drug Discovery|February 2, 2013
2012 FDA drug approvalsAsher Mullard
Journal of Neurosurgery. Spine|February 26, 2013
Harrington and scoliosisMarc Asher
Pageof 684